Healthcare -
Biotechnology - NASDAQ - US
$ 6.43
-2.43 %
$ 2.47 B
Market Cap
-3.8
P/E
RXRX - CHANGE IN WORKING CAPITAL
Change in Working Capital RXRX - Recursion Pharmaceuticals, Inc.
-50.3 M
LAST VALUE
-1181.56%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR